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Abstract
We recently reported the preferential accumulation of 8-hydroxydeoxyguanosine (8OHdG) adducts in cardiac
mitochondrial DNA (mtDNA) following acute intoxication of rats with doxorubicin (C.M. Palmeira et al., Biochim.
Biophys. Acta, 1321 (1997) 101^106). The concentration of 8OHdG adducts decreased to control values within 2 weeks.
Since conventional antineoplastic therapy entails repeated administration of small doses of doxorubicin, it was of interest to
characterize the kinetics for the accumulation and repair of 8OHdG adducts in the various DNA fractions. Weekly injections
of doxorubicin (2 mg/kg, i.p.) to adult male Sprague^Dawley rats caused a cumulative dose-dependent increase in the
concentration of 8OHdG adducts in both mtDNA and nuclear DNA (nDNA) from heart and liver. Following six weekly
injections, the concentration of 8OHdG in cardiac mtDNA was 50% higher than liver mtDNA and twice that of cardiac
nDNA. In contrast to the rapid repair of 8OHdG observed during the first days following an acute intoxicating dose of
doxorubicin, the concentration of 8OHdG adducts remained constant between 1 and 5 weeks following the last injection.
This was true for all DNA fractions examined. The cardioselective accumulation and persistence of 8OHdG adducts to
mtDNA is consistent with the implication of mitochondrial dysfunction in the cumulative and irreversible cardiotoxicity
observed clinically in patients receiving doxorubicin cancer chemotherapy. ß 1999 Elsevier Science B.V. All rights re-
served.
Keywords: Adriamycin; Doxorubicin; Mitochondrial DNA; 8-Hydroxydeoxyguanosine
8-Hydroxydeoxyguanosine (8OHdG) is one of sev-
eral DNA adducts and deletions that accumulate
over the life span of an individual [2^7]. Formation
of 8OHdG adducts is believed to re£ect the age-de-
pendent progressive uncoupling of oxidative metab-
olism and generation of free radical species of oxy-
gen, including the hydroxyl free radical which
hydroxylates deoxyguanosine preferentially at C8
[8]. As such, 8OHdG is suggested to provide a reli-
able indicator of the metabolic history and bioener-
getic capacity of the organism.
0005-2728 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
PII: S 0 0 0 5 - 2 7 2 8 ( 9 9 ) 0 0 0 1 1 - 0
* Corresponding author. Fax: +1-218-726-8014;
E-mail : kwallace@d.umn.edu
1 Supported in part by NIH Grant HL58016. The manuscript
was not subjected to internal Agency review and, thus, the opin-
ions are those of the authors and are not o⁄cially endorsed
by the U.S. Environmental Protection Agency. Mention of
trade names or commercial products does not constitute endorse-
ment nor is it intended to imply any form of judgment by the
authors.
BBABIO 44724 14-4-99
Biochimica et Biophysica Acta 1411 (1999) 201^205
8OHdG adducts accumulate to varying propor-
tions in di¡erent tissues, being most prevalent in mi-
totically ¢xed, metabolically active tissues such as
muscle and brain [9]. Furthermore, these adducts ac-
cumulate to a larger extent in mitochondrial DNA
(mtDNA) than in nuclear DNA (nDNA). This pref-
erential accumulation of adducts may re£ect either
more rapid rates of generation of oxygen free radi-
cals or slower rates of repair of the genetic damage in
the mitochondrion. For example, the age-dependent
increase in 8OHdG adducts to mtDNA correlates
with the lower coupling e⁄ciency and greater free
radical generation from the respiratory chain of
aged animals [6,7,10,11]. It is also consistent with
the initial reports of de¢cient mitochondrial DNA
repair activities compared to that associated with
the nucleus [12^18]. Regardless, it is the accumula-
tion of these adducts that is proposed to account for
the progressive decline in cognitive and physical per-
formance that accompanies aging.
The accumulation of 8OHdG adducts in mtDNA
is not limited to the normal physiological aging proc-
ess. Accelerated rates of accumulation of these ad-
ducts may also account for the pre-senescent cogni-
tive and myopathic changes associated with
numerous degenerative disorders, including; Alz-
heimer’s disease, progressive external ophthalmo-
plegia, Kearns^Sayre syndrome, MELAS, and in
Parkinson’s disease [19^21]. Furthermore, the ac-
cumulation of these adducts is also in£uenced by
extrinsic factors such as chemical exposures. Sub-
stantial increases in 8OHdG adducts to nuclear
DNA occurs in response to chronic feeding of rats
with ethanol [22] or to drugs that cause the prolifer-
ation of peroxisomes in liver tissue [23]. The tissue-
selective increase of 8OHdG adducts to hepatic, but
not renal, DNA following short-term intoxication of
rats with per£uorooctanoic acid or per£uorodecanoic
acid correlates with the target-organ speci¢city of
these chemicals, inferring a cause-and-e¡ect relation-
ship [23].
In view of the relationship between mtDNA tran-
scription and bioenergetic capacity of a tissue, it is
feasible that the accumulation of mitochondrial mu-
tations and the accompanying interference with tem-
plate activity, may be responsible for many of the
metabolic and bioenergetic de¢cits associated not
only with aging and neurodegenerative disease, but
also with chemical intoxications. We recently re-
ported that a single acute injection of rats with dox-
orubicin (15 mg/kg, i.p.) causes the preferential accu-
mulation of 8OHdG adducts to DNA in heart
compared to liver and that in both tissues, the con-
centration of adducts was 2-fold greater in mtDNA
than nDNA [1]. Of particular interest was the fact
that the increase in 8OHdG was transient in all tissue
fractions, returning to near control values within one
to two weeks. From this, we concluded that doxo-
rubicin is a mitochondrial mutagen, particularly in
heart, and that any resulting interference with
mtDNA transcription may account for the bioener-
getic failure associated with doxorubicin cardiomy-
opathy. However, doxorubicin is typically adminis-
tered subchronically, in divided doses over a period
of several months. The question then becomes
whether the kinetics of adduct formation and repair
or replacement are su⁄cient to warrant a concern for
the potential summation of genetic damage following
repetitive dosing with the drug.
To address the issue of cumulative toxicity, adult
male Sprague^Dawley rats (Harlan Labs, Madison,
WI) received 2^8 weekly i.p. injections of either dox-
orubicin (2 mg/kg) or an equivalent volume of saline
(1 ml/kg). The animals were housed in AAALAC-
accredited, climate-controlled facilities and allowed
free access to food (Purina rodent diet no. 5001)
and water. Animals were killed by decapitation 1^5
weeks after the last injection and the heart and liver
immediately excised to cold isotonic bu¡er. The tis-
sues were homogenized in a mixture containing 225
mM mannitol, 75 mM sucrose, 1 mM EGTA and 10
mM MOPS (pH 7.4), and the mitochondrial and
nuclear fractions isolated by di¡erential centrifuga-
tion [1]. Both fractions were then solubilized in
2.7% SDS and digested with proteinase K (400 Wg/
ml) for 3 h at 37‡C. DNA from the respective frac-
tion was extracted into phenol/chloroform/isoamyl
alcohol (25:24:1) and precipitated with isopropanol
at room temperature. The precipitate was digested
with RNases A and T1 and the DNA re-precipitated
and hydrolyzed to the individual nucleic acids by
digestion with DNase I, nuclease P1, and alkaline
phosphatase. The nucleic acids were stable for up
to 5 days when stored frozen at pH 7.8. The concen-
tration of 8OHdG in both the mtDNA and nDNA
fractions of heart and liver were quanti¢ed by LC/
BBABIO 44724 14-4-99
J. Serrano et al. / Biochimica et Biophysica Acta 1411 (1999) 201^205202
ESI/MS/MS [1,24] and is expressed relative to the
concentration of unmodi¢ed deoxyguanosine (dG)
bases.
The concentration of 8OHdG adducts to mtDNA
and nDNA of both heart and liver of saline-injected
rats was less than 5 adducts/105 dG and did not
change over the 11-week course of the experiment.
In contrast, 8OHdG ranged between 10 and 25 ad-
ducts/105 dG after as few as two weekly injections of
doxorubicin (Fig. 1). 8OHdG accumulated in cardiac
nDNA in proportion to the total cumulative dose of
doxorubicin, the concentration increasing in near lin-
ear fashion from 17 adducts/105 dG after the second
injection to 38/105 dG after eight weekly injections.
This contrasts with liver nDNA where the concen-
tration of 8OHdG reached a maximum of approxi-
mately 27/105 dG after the fourth dose. Additional
injections of doxorubicin did not cause further in-
creases in 8OHdG adducts to liver nDNA, suggest-
ing that a steady state was reached wherein the rate
of adduct formation equaled or was exceeded by the
rate of repair or replacement through cell turnover.
8OHdG adducts accumulated to a much greater
extent (ca. 2-fold) in mtDNA than nDNA of both
heart and liver, with the highest concentration of
adducts occurring in cardiac mtDNA (60^65
8OHdG/105 dG 1 week after eight injections, which
is about 50% higher than that for liver mtDNA). In
both tissues, the concentration of adducts increased
with successive doses of doxorubicin. However, the
incremental increase in 8OHdG became less with
successive doses, suggesting the eventual attainment
of a steady state that is determined by the balance of
the corresponding rates of formation and repair or
replacement.
Interestingly, the concentration of 8OHdG adducts
did not decrease over a 5-week period following dis-
continuation of drug administration in any of the
tissue fractions examined. This contrasts with the
rapid repair or dilution that occurs during the ¢rst
week following a single high dose of doxorubicin [1].
The data indicate that essentially all of the repair or
replacement through cell proliferation is complete
within the ¢rst week. Adducts which are not repaired
within this timeframe are stable and accumulate with
successive weekly injections of doxorubicin.
The preferential accumulation of adducts in heart
as compared to liver indicates either that the rate of
formation of 8OHdG is greater or that the rate of
repair is lower in cardiac tissue. Although there are
no data for the formation of 8OHdG, the stimula-
tion of superoxide anion radical generation by doxo-
rubicin is 5-fold greater in heart compared to liver
mitochondria [25]. Scheulen et al. [26,27] reported
that the rate of activation and covalent binding of
doxorubicin metabolites to microsomal proteins in
vitro is almost 10-fold greater for heart than liver
cell fractions. It is possible that this re£ects in part
the fact that cardiac tissue is mitotically ¢xed and
cannot replace altered genomes and oxidized proteins
by stimulating cell proliferation. Dusonchet et al. [28]
found that the rate of unscheduled DNA synthesis
following subchronic doxorubicin administration to
Fig. 1. Cumulative-dose-dependent oxidation of mitochondrial
and nuclear DNA. Rats received from two to eight weekly in-
jections of 2 mg (i.p.) doxorubicin/kg (tx). The concentration of
8OHdG was quanti¢ed by LC/ESI/MS/MS and expressed rela-
tive to the concentration of unmodi¢ed dG. Rats were killed
1 week following the last injection and both mtDNA and
nDNA isolated from heart and liver (solid lines). Data points
connected by broken lines represent the concentration of ad-
ducts in samples harvested from animals that received either six
or eight weekly doses of doxorubicin then allowed to recover
for up to 5 weeks with no further injections. Each point repre-
sents the mean of duplicate measurements from pooled tissues
from two rats each. The corresponding concentration of ad-
ducts to cardiac and liver nDNA and mtDNA from paired con-
trol rats that received parallel injections of isotonic NaCl was
invariably less than 5/105 dG at all treatment times.
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mice is substantially lower in heart than liver. Thus,
the cardioselective accumulation of 8OHdG is con-
sistent with high rates of formation and a lower ca-
pacity for repair or replacement of oxidized DNA
adducts in heart.
The preferential accumulation of mtDNA adducts
agrees with previous reports [1,7] and suggests a
higher rate of doxorubicin-stimulated hydroxyl radi-
cal generation and 8OHdG formation and/or a slow-
er rate of repair in the mitochondrion compared to
the nucleus. Although little is known regarding the
relative rates of drug-induced free radical generation
in the nuclear and mitochondrial compartments, the
metabolism of doxorubicin by isolated intact rat liver
nuclei is very low, amounting to only 5% that of the
microsomal fraction of the same tissue [29]. In con-
trast, doxorubicin stimulates a very high rate of free
radical generation from the mitochondrial electron
transport chain [30,31]. Giulivi et al. [32] character-
ized a strong correlation between the rate of gener-
ation of hydroxyl free radicals in submitochondrial
particles and the occurrence of 8OHdG adducts to
the mitochondrial genome. Accordingly, it is prob-
able that doxorubicin stimulates high rates of forma-
tion of 8OHdG in the immediate vicinity of the
mtDNA. Once formed, however, the rates of repair
of mtDNA adducts may be no di¡erent than that
which occurs in the nucleus [14,30], despite initial
reports of de¢ciencies in mtDNA repair enzymes.
Thus, the preferential accumulation of mtDNA ad-
ducts more likely re£ects a more rapid rate of for-
mation than a de¢ciency in DNA repair.
In summary, cumulative doses of doxorubicin
cause a progressive accumulation of 8OHdG adducts
to both nDNA and mtDNA that are stable for up to
5 weeks following discontinuation of drug dosing.
Inasmuch as these adducts accumulate at doses that
do not alter body or organ weights, this appears to
represent an early response to doxorubicin intoxica-
tion. The cardioselective accumulation of mitochon-
drial adducts is of particular interest in that it con-
trasts with the fact that the drug itself is retained
much longer in the liver than heart and that it con-
centrates in the nuclear fraction (as opposed to mi-
tochondrial fraction) in both tissues [33]. This dispar-
ity indicates that it is not the presence of the drug or
its major metabolites that is the principal determi-
nant of 8OHdG adduct accumulation in the di¡erent
tissue fractions. Since expression of the mitochon-
drial genome is essential to the integrity of the res-
piratory chain, the preferential oxidation of mtDNA
would indicate the eventual disruption of mitochon-
drial structure and deterioration in bioenergetic func-
tion. Both phenomena are early and prominent fea-
tures associated with the experimental manifestation
of doxorubicin-induced cardiomyopathy [34^37]. Ac-
cordingly, one could invoke this dose-dependent ac-
cumulation of cardiac mtDNA adducts as a potential
cause of the cumulative and irreversible cardiomyo-
pathy observed clinically.
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